Crabel Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,783
Closed -$569K 55
2025
Q3
$569K Buy
+6,783
New +$559K 0.51% 35
2025
Q2
Sell
-3,040
Closed -$273K 51
2025
Q1
$273K Buy
+3,040
New +$284K 0.29% 41
2023
Q4
Sell
-7,878
Closed -$811K 139
2023
Q3
$811K Buy
+7,878
New +$849K 0.65% 35
2023
Q1
Sell
-2,467
Closed -$274K 91
2022
Q4
$274K Buy
+2,467
New +$252K 0.1% 84
2020
Q1
Sell
-4,870
Closed -$423K 108
2019
Q4
$423K Buy
4,870
+559
+13% +$45.9K 0.16% 84
2019
Q3
$346K Buy
+4,311
New +$346K 0.21% 85

Other funds holding MRK

Crabel Capital Management's MRK Position: Q4 2025 in Review

Crabel Capital Management sold out of Merck (MRK) in Q4 2025, closing a stake of 6,783 shares — an estimated $569K sold.

Crabel Capital Management first reported a position in MRK in Q3 2019 and held it in 6 quarters. The position peaked at $811K in Q3 2023. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Crabel Capital Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Crabel Capital Management sold 6,783 Merck shares in Q4 2025, an estimated $569K.
  • Crabel Capital Management first reported a position in Merck in Q3 2019 and held it in 6 quarters.
  • Crabel Capital Management's Merck position peaked at $811K in Q3 2023.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Crabel Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.